Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORISC Trial
NCT06702553Phase 3Recruiting
- Sponsor
- Xijing Hospital
- Start
- May 2025
- Primary completion
- Mar 2028
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 3
01
Overview
A Phase 3 trial of nitric oxide in postoperative complications, sponsored by Xijing Hospital. Started May 2025; status: recruiting.
02
Drugs
nitric oxide
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT06702553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06702553.